Atlas Trials

Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients

Clinical trial NCT06657755 · COMPLETED

Trial details

NCT number
NCT06657755
Sponsor
Lanzhou University Second Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Bladder (Urothelial, Transitional Cell) Cancer
Start date
2024-06-01
Primary completion
2024-10-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.